Federal Circuit / U.S. Court of Spec. Jurisdiction

Federal Circuit / U.S. Court of Spec. Jurisdiction
(incl: International Trade (Customs), Federal Claims, Armed Forces, Federal Adm. Agencies & Boards, Immigration, Tax, Gov. Personnel Appeals, Patent , Trademark, Veterans Appeals, etc.)

Custom text Title Organization
Feb
3
2020
 PTAB Strict on Motivation Evidence for Obviousness Foley & Lardner LLP
Aug
25
2020
 Federal Circuit Upholds Tangentiality Exception To Prosecution History Estoppel Under Doctrine Of Equivalents Foley & Lardner LLP
Oct
7
2020
 Federal Circuit Orders Partial Dismissal of Voip-Pal’s IPR Challenged Claims Foley & Lardner LLP
Jul
8
2023
 Full Federal Circuit Set to Consider Changing the Test for Obviousness of Design Patents Foley & Lardner LLP
May
6
2015
 Federal Circuit Keeps Sandoz Biosimilar Off The Market For Now Foley & Lardner LLP
Aug
23
2023
 Nothing for Free: Federal Circuit Clarifies Commercial Success is All About Sales Foley & Lardner LLP
Jan
31
2024
 Sotera Stipulation Filed After the Patent Owner’s Response Still Deemed Effective Foley & Lardner LLP
Mar
27
2024
 Federal Circuit Applies Safe Harbor to Imported Medical Device Samples Foley & Lardner LLP
Jun
18
2015
 USPTO Pilots Expedited Patent Appeal Program But at What Price? Foley & Lardner LLP
Jun
22
2015
 Unfortunately, Offensive Racial Comments Don’t Always Get You Fired (At Least Under Labor Law) Foley & Lardner LLP
Aug
11
2015
 Invalidity Argument Without a Home? PTAB's Discretion to Ignore Grounds for Invalidity Foley & Lardner LLP
Dec
17
2015
 Federal Circuit Affirms PTAB's IPR Decision Invalidating A Pharmaceutical Patent Foley & Lardner LLP
Jan
7
2016
 Share Your Patent Quality Pet Peeves with the USPTO Foley & Lardner LLP
Jan
19
2016
 PTAB Denies Challenge Of Abbvie Humira Patents Foley & Lardner LLP
Feb
18
2016
 Sandoz Asks Supreme Court To Reverse Biosimilar Decision Foley & Lardner LLP
Aug
25
2016
 The Evolving Standard for Pleading Direct Patent Infringement Foley & Lardner LLP
Sep
21
2016
 Inherent Disclosure Satisfied Written Description Foley & Lardner LLP
Oct
25
2016
 Pharmaceutical Biogen TYSABRI Patents Spared Inter Partes Review Foley & Lardner LLP
Feb
27
2017
 Expansion of the Patent-Ineligibility Doctrine: Are Method of Treatment Claims Patent-Eligible? Foley & Lardner LLP
Jun
12
2017
 Supreme Court Decision Largely Favors Biosimilar Applicants Foley & Lardner LLP
Oct
10
2017
 Federal Circuit Questions Written Description For Antibody Claims Foley & Lardner LLP
Feb
19
2018
 Federal Circuit: Rare Guidance on Subject Matter Eligibility of Software Claims Foley & Lardner LLP
Feb
26
2018
 Board Rules that Tribal Immunity is Unavailable to Avoid Inter Partes Review Challenge Foley & Lardner LLP
May
15
2018
 Claim Construction Of An Enantiomeric Chemical Structure Foley & Lardner LLP
Aug
7
2018
 Sales Catalog From Dealer Trade Show Qualifies As Printed Publication Foley & Lardner LLP
Dec
4
2018
 PTAB SOP 1 Explains APJ Paneling Process Foley & Lardner LLP
Mar
11
2019
 New Guidance from Federal Circuit for Computer-Implemented Medical Methods Foley & Lardner LLP
Apr
23
2019
 Federal Circuit Scrutinizes Written Description In Provisional Application Foley & Lardner LLP
May
20
2019
 Federal Circuit Invalidates Patented Cancer Therapy Foley & Lardner LLP
Jul
9
2019
 Automotive Market Intelligence Foley & Lardner LLP
Oct
15
2019
 Federal Circuit Reverses PTAB On Reasonable Expectation Of Success For TARCEVA Patent Foley & Lardner LLP
Feb
25
2020
 Necessity Is The Mother Of Single Reference Anticipation By Inherency Foley & Lardner LLP
Aug
11
2020
 Federal Circuit Finds Significant Contributions For Co-Inventorship Foley & Lardner LLP
Aug
17
2021
 Qualcomm Prevails at Federal Circuit Based on Lack of Notice and Adequate Opportunity to Respond Foley & Lardner LLP
Mar
2
2015
 Federal Circuit Upholds Patent Term Adjustment Deduction For IDS Filed After Restriction Requirement Foley & Lardner LLP
Subscribe to Federal Circuit / U.S. Court of Spec. Jurisdiction
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins